139 related articles for article (PubMed ID: 38636400)
41. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy.
Al-Damry NT; Attia HA; Al-Rasheed NM; Al-Rasheed NM; Mohamad RA; Al-Amin MA; Dizmiri N; Atteya M
Biomed Pharmacother; 2018 Nov; 107():347-358. PubMed ID: 30099338
[TBL] [Abstract][Full Text] [Related]
42. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
[TBL] [Abstract][Full Text] [Related]
43. Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy.
Kong C; Guo Z; Liu F; Tang N; Wang M; Yang D; Li C; Yang Z; Ma Y; Wang P; Tang Q
J Adv Res; 2024 Jul; 61():65-81. PubMed ID: 37625569
[TBL] [Abstract][Full Text] [Related]
44. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
45. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
[TBL] [Abstract][Full Text] [Related]
46. Knockout of CNR1 prevents metabolic stress-induced cardiac injury through improving insulin resistance (IR) injury and endoplasmic reticulum (ER) stress by promoting AMPK-alpha activation.
Pei SJ; Zhu HY; Guo JH; Zhang X; Deng ZJ
Biochem Biophys Res Commun; 2018 Sep; 503(2):744-751. PubMed ID: 29909009
[TBL] [Abstract][Full Text] [Related]
47. GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress.
Feng W; Lei T; Wang Y; Feng R; Yuan J; Shen X; Wu Y; Gao J; Ding W; Lu Z
Free Radic Biol Med; 2019 Jan; 130():128-139. PubMed ID: 30389499
[TBL] [Abstract][Full Text] [Related]
48. NLRC5 deficiency ameliorates cardiac fibrosis in diabetic cardiomyopathy by regulating EndMT through Smad2/3 signaling pathway.
Wang B; Wu Y; Ge Z; Zhang X; Yan Y; Xie Y
Biochem Biophys Res Commun; 2020 Jul; 528(3):545-553. PubMed ID: 32505342
[TBL] [Abstract][Full Text] [Related]
49. Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway.
Yuan Q; Zhou QY; Liu D; Yu L; Zhan L; Li XJ; Peng HY; Zhang XL; Yuan XC
Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):127-33. PubMed ID: 24341361
[TBL] [Abstract][Full Text] [Related]
50. Calhex
Yuan H; Xu J; Xu X; Gao T; Wang Y; Fan Y; Hu J; Shao Y; Zhao B; Li H; Sun J; Xu C
Biol Pharm Bull; 2019 Aug; 42(8):1337-1344. PubMed ID: 31167987
[TBL] [Abstract][Full Text] [Related]
51. Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects.
Li R; Liu Y; Shan YG; Gao L; Wang F; Qiu CG
Oxid Med Cell Longev; 2019; 2019():3206542. PubMed ID: 31354905
[TBL] [Abstract][Full Text] [Related]
52. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
[TBL] [Abstract][Full Text] [Related]
53. Exogenous H2S Protects Against Diabetic Cardiomyopathy by Activating Autophagy via the AMPK/mTOR Pathway.
Yang F; Zhang L; Gao Z; Sun X; Yu M; Dong S; Wu J; Zhao Y; Xu C; Zhang W; Lu F
Cell Physiol Biochem; 2017; 43(3):1168-1187. PubMed ID: 28977784
[TBL] [Abstract][Full Text] [Related]
54. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
55. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
[TBL] [Abstract][Full Text] [Related]
56. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
[TBL] [Abstract][Full Text] [Related]
57. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
Liu P; Su J; Song X; Wang S
Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
[TBL] [Abstract][Full Text] [Related]
58. Guan Xin Dan Shen formulation protects
Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
[TBL] [Abstract][Full Text] [Related]
59. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
[TBL] [Abstract][Full Text] [Related]
60. Tetrahydrocurcumin Ameliorates Diabetic Cardiomyopathy by Attenuating High Glucose-Induced Oxidative Stress and Fibrosis via Activating the SIRT1 Pathway.
Li K; Zhai M; Jiang L; Song F; Zhang B; Li J; Li H; Li B; Xia L; Xu L; Cao Y; He M; Zhu H; Zhang L; Liang H; Jin Z; Duan W; Wang S
Oxid Med Cell Longev; 2019; 2019():6746907. PubMed ID: 31210844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
